MED
Company Description
Medifast, Inc., through its various divisions, develops and provides a range of consumable health and nutritional items tailored for weight loss, weight management, and general wellness. These products are distributed across the United States and the Asia-Pacific region. Their extensive portfolio encompasses snack bars, savory bites, cereals, drinks, substantial meal choices, oatmeal, pancakes, puddings, soft serves, shakes, smoothies, baked goods, and soups. These offerings are marketed under proprietary brands like OPTAVIA, Optimal Health by Take Shape for Life, and Flavors of Home. The company facilitates sales primarily through direct e-commerce transactions. Established in 1980, Medifast, Inc. maintains its corporate headquarters in Baltimore, Maryland.
Track Record
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 385.79M | 602.46M | 1.07B | 1.60B | 1.53B | 934.84M | 713.67M | 501.00M | 301.56M | 274.53M | 272.77M | 285.29M |
| Net Income | (18.67M) | 2.09M | 99.42M | 143.57M | 164.03M | 102.86M | 77.92M | 55.79M | 27.72M | 17.84M | 20.06M | 13.18M |
| EPS | -1.70 | 0.19 | 9.10 | 12.82 | 14.01 | 8.74 | 6.62 | 4.67 | 2.32 | 1.51 | 1.68 | 1.04 |
| Free Cash Flow | 1.25M | 17.02M | 141.17M | 177.89M | 60.34M | 139.31M | 74.20M | 55.88M | 39.99M | 22.47M | 26.59M | 18.51M |
| FCF / Share | 0.11 | 1.56 | 12.97 | 15.89 | 5.15 | 11.83 | 6.30 | 4.68 | 3.35 | 1.90 | 2.22 | 1.46 |
| Operating CF | 6.86M | 24.48M | 147.66M | 194.57M | 94.55M | 145.20M | 84.26M | 60.82M | 43.24M | 25.35M | 29.41M | 25.54M |
| Total Assets | 257.01M | 284.21M | 309.91M | 316.21M | 398.33M | 276.08M | 194.65M | 169.43M | 145.93M | 121.22M | 117.33M | 115.91M |
| Total Debt | 16.79M | 16.12M | 22.01M | 26.05M | 32.54M | 11.16M | 13.60M | 0 | 0 | 779,000 | 219,000 | 474,000 |
| Cash & Equiv | 89.30M | 90.93M | 94.44M | 87.69M | 104.18M | 163.72M | 76.97M | 81.36M | 75.08M | 52.44M | 42.04M | 24.46M |
| Book Value | 198.92M | 210.11M | 201.48M | 155.04M | 202.47M | 157.25M | 104.83M | 109.11M | 108.58M | 96.02M | 88.58M | 80.48M |
| Return on Equity | -0.09 | 0.01 | 0.49 | 0.93 | 0.81 | 0.65 | 0.74 | 0.51 | 0.26 | 0.19 | 0.23 | 0.16 |
| Metric | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 76.04M | 75.10M | 89.41M | 105.56M | 115.73M | 119.00M | 140.16M | 168.56M | 174.74M | 191.01M | 235.87M | 296.19M |
| Net Income | (2.12M) | (18.12M) | (2.26M) | 2.48M | (772,000) | 801,000 | 1.13M | (8.15M) | 8.32M | 6.04M | 23.13M | 30.28M |
| EPS | -0.19 | -1.65 | -0.21 | 0.23 | -0.07 | 0.07 | 0.10 | -0.75 | 0.76 | 0.50 | 2.12 | 2.78 |
| Free Cash Flow | (836,000) | (6.63M) | 10.75M | (4.76M) | 1.88M | (7.23M) | 7.68M | 11.13M | 5.44M | 9.58M | 28.25M | 41.40M |
| FCF / Share | -0.08 | -0.60 | 0.98 | -0.43 | 0.17 | -0.66 | 0.70 | 1.02 | 0.50 | 0.88 | 2.59 | 3.80 |
| Operating CF | 260,000 | (5.28M) | 12.11M | (3.38M) | 3.41M | (4.95M) | 9.07M | 13.07M | 7.28M | 10.52M | 29.93M | 43.15M |
| Total Assets | 252.05M | 257.01M | 268.21M | 269.33M | 280.01M | 284.21M | 291.24M | 293.53M | 302.76M | 309.91M | 320.02M | 318.73M |
| Total Debt | 16.10M | 16.79M | 12.26M | 13.07M | 14.61M | 16.12M | 17.62M | 19.10M | 20.57M | 22.01M | 22.34M | 23.67M |
| Cash & Equiv | 71.53M | 89.30M | 99.53M | 101.69M | 91.72M | 90.93M | 115.31M | 108.02M | 97.47M | 94.44M | 112.75M | 147.41M |
| Book Value | 197.68M | 198.92M | 214.71M | 216.00M | 210.96M | 210.11M | 207.34M | 205.28M | 210.96M | 201.48M | 193.03M | 185.56M |
| Return on Equity | -0.01 | -0.09 | -0.01 | 0.01 | -0.00 | 0.00 | 0.01 | -0.04 | 0.04 | 0.03 | 0.12 | 0.16 |